CD4 and diabetes mellitus: Likewise, splenic tetramer+ (but not tetramer−) CD4+ T cells from BDC2.5 mi/I-Ag7-NP-treated donors suppressed diabetes development in T-cell-reconstituted NOD.Scid hosts [11].